# China Stroke Secondary Prevention Trial

> **NCT01317849** · NA · WITHDRAWN · sponsor: **Xijing Hospital**

## Conditions studied

- Stroke
- Transient Ischemic Attack

## Interventions

- **DRUG:** Folic Acid
- **DRUG:** Vitamin B6
- **DRUG:** Vitamin B12
- **DRUG:** placebo
- **DRUG:** placebo
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01317849
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-07
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** financial assistance financial assistance financial assistance financial assistance financial assistance without financial assistance
- **Last updated:** 2014-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01317849

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01317849, "China Stroke Secondary Prevention Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01317849. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*